Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine - Case report

Pharmacopsychiatry

Volumn 44, Issue 2, 2011, Pages 75-76

  Himmighoffen, H ^a   Seifritz, E ^a   Boeker, H ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLOMIPRAMINE; DULOXETINE; LORAZEPAM; MAPROTILINE; MIANSERIN; OLANZAPINE; PREGABALIN; QUETIAPINE; SERTRALINE; VENLAFAXINE; ZOLPIDEM;

ADD ON THERAPY; ADULT; ANXIETY DISORDER; CASE REPORT; CLINICAL EXAMINATION; DEPRESSION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; FIBROMYALGIA; HUMAN; LABORATORY TEST; MYOCLONUS; NEUROPATHIC PAIN; PAIN; PRIORITY JOURNAL; REVIEW; SEROTONIN SYNDROME; WEIGHT GAIN;

BENZODIAZEPINES; DEPRESSIVE DISORDER; FEMALE; HUMANS; MIDDLE AGED; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 79953051517     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1268420     Document Type: Review

References (17)

1. Shelton RC, Tollefson GD, Tohen M et al,. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 2001 158 131-134 (Pubitemid 32047260)
2. National Institute for Health and Clinical Excellence (NICE). Depression: the treatment and management of depression in adults (update). NICE [Internet]. 2009 [cited 2010 Jan 20]. Available from: http://guidance.nice.org.uk/CG9
3. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991 148 705-713
4. Dunkley EJC, Isbister GK, Sibbritt D et al,. The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. Q J Med 2003 96 635-642 (Pubitemid 37063272)
5. Hegerl U, Bottlender R, Gallinat J et al,. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998 248 96-103 (Pubitemid 28279551)
6. Hadikusumo B, Ng B. Serotonin syndrome induced by duloxetine. Aust N Z J Psychiatry 2009 43 581-582
7. Jimenez-Genchi A. Immediate switching from moclobemide to duloxetine may induce serotonin syndrome. J Clin Psychiatry 2006 67 1821-1822 (Pubitemid 44955170)
8. Strouse T, Kerrihard TN, Forscher CA et al,. Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine. J Clin Psychopharmacology 2006 26 681-683 (Pubitemid 44772758)
9. Dursun SM, Burke JG, Reveley MA. Toxic serotonin syndrome or extrapyramidal side-effects? Br J Psychiatry 1995 166 401-402
10. Boyer EW, Shanon M. The serotonin syndrome. N Engl J Med 2005 352 1112-1120
11. Sun-Edelstein C, Tepper SJ, Shapiro RE. Drug-induced serotonin syndrome: a review. Expert Opin Drug Saf 2008 7 587-596
12. Duggal HS, Fetchko J. Serotonin syndrome and atypical antipsychotics. Am J Psychiatry 2002 159 672-673
13. Haslett CD, Kumar S. Can olanzapine be implicated in causing serotonin syndrome? Psychiatry Clin Neurosci 2002 56 533-535
14. Isbister GF, Downes F, Whyte IM. Olanzapine and serotonin toxicity. Psych Clin Neurosci 2003 57
15. Richelson E. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 1999 60 suppl 10 5-14 (Pubitemid 29237170)
16. Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors: Focus on newer generation compounds. Life Sci 2000 68 29-39
17. Boddy R, Ali R, Dowsett R. Use of sublingual olanzapine in serotonin syndrome (abstract). Clin Toxicol 2004 42 725